Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP332046.RAie029r7KupxAd3-uZ7eIylHVk8az9xN8TfeKI8bF_oo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP332046.RAie029r7KupxAd3-uZ7eIylHVk8az9xN8TfeKI8bF_oo130_assertion type Assertion NP332046.RAie029r7KupxAd3-uZ7eIylHVk8az9xN8TfeKI8bF_oo130_head.
- NP332046.RAie029r7KupxAd3-uZ7eIylHVk8az9xN8TfeKI8bF_oo130_assertion description "[G-CSF has also been applied in priming strategies designed to enhance the sensitivity of leukemia stem cells to cytotoxic agents, in protocols aimed to induce their differentiation and accompanying growth arrest and cell death, and in severe aplastic anemia and myelodysplastic syndrome (MDS) to alleviate anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332046.RAie029r7KupxAd3-uZ7eIylHVk8az9xN8TfeKI8bF_oo130_provenance.
- NP332046.RAie029r7KupxAd3-uZ7eIylHVk8az9xN8TfeKI8bF_oo130_assertion evidence source_evidence_literature NP332046.RAie029r7KupxAd3-uZ7eIylHVk8az9xN8TfeKI8bF_oo130_provenance.
- NP332046.RAie029r7KupxAd3-uZ7eIylHVk8az9xN8TfeKI8bF_oo130_assertion SIO_000772 20237318 NP332046.RAie029r7KupxAd3-uZ7eIylHVk8az9xN8TfeKI8bF_oo130_provenance.
- NP332046.RAie029r7KupxAd3-uZ7eIylHVk8az9xN8TfeKI8bF_oo130_assertion wasDerivedFrom befree-20150227 NP332046.RAie029r7KupxAd3-uZ7eIylHVk8az9xN8TfeKI8bF_oo130_provenance.
- NP332046.RAie029r7KupxAd3-uZ7eIylHVk8az9xN8TfeKI8bF_oo130_assertion wasGeneratedBy ECO_0000203 NP332046.RAie029r7KupxAd3-uZ7eIylHVk8az9xN8TfeKI8bF_oo130_provenance.